4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001672659-26-000006
Chief Medical Officer sold 19,076 shares at an average $32.66 ($623,115)
- Chief Medical Officer acquired 7,709 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2026-01-13 | Option exercise 10b5-1 | +3,542 | $10.20 | $36,128 | 65,346 | D |
| Rodman David Malcom Chief Medical Officer | 2026-01-13 | Option exercise 10b5-1 | +4,167 | $14.25 | $59,380 | 69,513 | D |
| Rodman David Malcom Chief Medical Officer | 2026-01-13 | Sale 10b5-1 | −7,709 | $32.75 | $252,470 | 61,804 | D |
| Rodman David Malcom Chief Medical Officer | 2026-01-14 | Sale 10b5-1 | −11,367 | $32.61 | $370,645 | 50,437 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2026-01-13 | Option exercise · Stock Option 10b5-1 | −3,542 | 131,042 | D | ||
| Rodman David Malcom Chief Medical Officer | 2026-01-13 | Option exercise · Stock Option 10b5-1 | −4,167 | 104,167 | D | ||
| Open-market sales · 19,076 sh · avg $32.66 · $623,115 | |||||||
Loading xslF345X05/wk-form4_1768522053.xml…